Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later

ConditionsOsteoperosis Femoral Neck Fractures Anticoagulant Therapy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorMeir Hospital, Kfar Saba, Israel

About this trial

until today we waited at least 24 hours before surgery of femoral neck fractures in patients who take anticouagolation . in our new reasearch we belive that patients who take NOAC can go under surgery earlier with minimal risk

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

under 18 y.o

anti platelet therapy (aspirin is not included)

creatinine clearance under 50

active anti cancer therapy

Trial population

patients with femoral neck fracture thattake noac and arrive at meir hospital and need surgery

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

femoral neck CRIF
Procedure/Surgery
femoral neck fracture CRiF while under noac. no special intervention beside taking blood test for drug levels

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: early surgery1 intervention

Group B: late surgery1 intervention

Trial outcomes

Primary outcomes

bleeding

Time frame

30 days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Meir Hospital, Kfar Saba, Israel

Lead sponsor

Source ClinicalTrials.gov

Apply now